This alert is part of Wolf Greenfield's design patents page. To learn more about design patents, click here. Proposed amendments to the Australian design right laws are currently before Parliament for...
This alert is part of Wolf Greenfield's COVID-19 Resource Center. To access the full resource center, click here. NINTH UPDATE: THE FOLLOWING CONTENT WAS ADDED JANUARY 20, 2021 As vaccine efforts move...
The Trademark Modernization Act of 2020 (“TMA”) — signed into law by President Trump on December 27, 2020 as part of the COVID-19 relief and government funding package — provides trademark owners with...
The United Kingdom left the European Union on January 31, 2020 and is now in a transition period set to last until December 31, 2020. Since EU rights will eventually terminate in the UK, a few key cha...
This alert is part of Wolf Greenfield's COVID-19 Resource Center. To access the full resource center, click here. On May 29, 2020, we issued an IP Alert on the announcement by the USPTO to extend cert...
This alert is part of Wolf Greenfield's COVID-19 Resource Center. To access the full resource center, click here. The USPTO has extended the time to file certain patent-related documents and to pay ce...
This alert is part of Wolf Greenfield's COVID-19 Resource Center. To access the full resource center, click here. The USPTO has extended the time to file certain patent and trademark-related documents...
Introduction On April 23, 2020, the Supreme Court held that the federal Trademark Act (the Lanham Act) does not require that a plaintiff show that an accused infringer “willfully” infringed in order f...
This alert is part of Wolf Greenfield's COVID-19 Resource Center. To access the full resource center, click here. On March 31, 2020, the USPTO announced the availability of 30-day extensions of time f...
This IP alert is part of Wolf Greenfield's COVID-19 Resource Center. To access the full resource center, click here. The US Patent and Trademark Office (“USPTO”) is implementing an important change th...
Introduction On January 22, 2019, the Supreme Court issued a decision in Helsinn Healthcare S.A. et al. v. Teva Pharmaceuticals USA, Inc., No. 17-1229. The Supreme Court unanimously held that the Amer...
The United States Patent and Trademark Office recently released new guidance to its examiners on how claims are to be examined under 35 U.S.C. § 101, to determine whether claims recite patent-eligible...